The pharmaceutical company is joining the Global Chagas Disease Coalition to help improve access to diagnosis and treatment for people suffering from Chagas. Additionally, Novartis has announced the launch of a multinational study in people suffering from the Neglected Tropical Disease. Chagas disease, also known as American trypanosomiasis, affects over a six million people worldwide. ...
